Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Okumura

Showing results (1-10 of 454) with videos related to

Pageof 46
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 25, 2012
[Programs for continuing medical education: B session; 2. Guideline-directed treatments of atrial fibrillation and premature ventricular contraction]Ken Okumura
Journal of Arrhythmia|September 4, 2015
Celebrating a launch of new scientific societyKen Okumura
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 11, 2012
[The cutting-edge of medicine; the frontline of the treatment of atrial fibrillation: anticoagulation therapy and catheter ablation]Ken Okumura
Journal of Cardiovascular Electrophysiology|February 16, 2019
Does cryomapping warrant a safety in the subsequent therapeutic cryoablation?Ken Okumura
Journal of Cardiovascular Electrophysiology|August 2, 2007
Extracellular matrix remodeling as a cause of persistent atrial fibrillation: another therapeutic targetKen Okumura
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 16, 2010
[Current state and perspectives of pharmacological and non-pharmacological treatment of atrial fibrillation: overview]Ken Okumura
Cardiac Electrophysiology Review|May 2, 2002
Idiopathic left ventricular tachycardia: clinical features, mechanisms and managementKen Okumura, Takeshi Tsuchiya
Circulation Journal : Official Journal of the Japanese Circulation Society|March 31, 2015
Is low body weight a novel risk factor for thromboembolic events in patients with non-valvular atrial fibrillation?Hirofumi Tomita, Ken Okumura
Journal of Cardiology|October 25, 2025
Current risk stratification schemes for preventing ischemic stroke in patients with nonvalvular atrial fibrillation: HELT-E<sub>2</sub>S<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VA scoresHirofumi Tomita, Ken Okumura
Circulation Research|April 28, 2007
Therapeutic challenge to adiposity of the heartTomohiro Osanai, Ken Okumura
Pageof 46

Showing results (1-10 of 454) with videos related to

Sort By:
Pageof 46
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 25, 2012
[Programs for continuing medical education: B session; 2. Guideline-directed treatments of atrial fibrillation and premature ventricular contraction]Ken Okumura
Journal of Arrhythmia|September 4, 2015
Celebrating a launch of new scientific societyKen Okumura
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 11, 2012
[The cutting-edge of medicine; the frontline of the treatment of atrial fibrillation: anticoagulation therapy and catheter ablation]Ken Okumura
Journal of Cardiovascular Electrophysiology|February 16, 2019
Does cryomapping warrant a safety in the subsequent therapeutic cryoablation?Ken Okumura
Journal of Cardiovascular Electrophysiology|August 2, 2007
Extracellular matrix remodeling as a cause of persistent atrial fibrillation: another therapeutic targetKen Okumura
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 16, 2010
[Current state and perspectives of pharmacological and non-pharmacological treatment of atrial fibrillation: overview]Ken Okumura
Cardiac Electrophysiology Review|May 2, 2002
Idiopathic left ventricular tachycardia: clinical features, mechanisms and managementKen Okumura, Takeshi Tsuchiya
Circulation Journal : Official Journal of the Japanese Circulation Society|March 31, 2015
Is low body weight a novel risk factor for thromboembolic events in patients with non-valvular atrial fibrillation?Hirofumi Tomita, Ken Okumura
Journal of Cardiology|October 25, 2025
Current risk stratification schemes for preventing ischemic stroke in patients with nonvalvular atrial fibrillation: HELT-E<sub>2</sub>S<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>-VA scoresHirofumi Tomita, Ken Okumura
Circulation Research|April 28, 2007
Therapeutic challenge to adiposity of the heartTomohiro Osanai, Ken Okumura
Pageof 46